Radionetics Oncology Enters Into Strategic Agreement With Lilly

SAN DIEGO, CA - JULY 1, 2024 - Radionetics Oncology a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted …

CouponFollow Extension

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$140
OFF

Radionetics Oncology Enters Into Strategic Agreement With Lilly

4 weeks from now

Jul 1, 2024 · Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics to receive $140 million upfront payment

businesswire.com

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. …

pmlive.com

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Oct 10, 2024 · Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G …

biotech-today.com

$140
OFF

Lilly Builds In Radiopharma With $140m Radionetics Deal

4 weeks from now

4 days ago · Meanwhile, in May, Lilly paid $60 million upfront to use Aktis Oncology's technology to generate radiopharma candidates for solid tumours in a deal that could be worth up to $1.1 …

pharmaphorum.com

$140
OFF

Radionetics

4 weeks from now

Radionetics provides Lilly access to proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics receives $140 million upfront payment and Lilly obtains the …

radionetics.com

$140
OFF

Lilly Signs $140M Upfront Partnership With Radionetics In Latest ...

4 weeks from now

Oct 10, 2024 · The agreement also gives Lilly the option to buy the Crinetics spinout for a cool $1 billion at the end of an exercise period. Lilly dived into the nascent radiopharma space by …

biotech-insider.com

$140
OFF

Lilly Inks Radiopharma Deal With Radionetics, With Rights To Buy The ...

4 weeks from now

Jul 1, 2024 · Eli Lilly is further delving into the radiopharmaceutical field with a $140 million upfront deal with Radionetics Oncology. The strategic pact with the San Diego biotech could turn into a ...

endpts.com

$140
OFF

Lilly Adds To Radiopharma Arsenal With Option To Buy …

4 weeks from now

Lilly paid $140m up front for an option to acquire Radionetics for $1bn within an undisclosed timeframe. The private firm is developing small molecule GPCR-targeted …

citeline.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New …

4 weeks from now

May 21, 2024 · Drugmaker Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with biotechnology firm Aktis Oncology. Under terms of the …

radiologybusiness.com

FAQs about Radionetics Oncology Enters Into Strategic Agreement With Lilly Coupon?

Why did Lilly acquire radionetics?

Radionetics provides Lilly access to proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics receives $140 million upfront payment and Lilly obtains the exclusive right to acquire Radionetics for $1 billion. We have a strong sense of purpose and urgency to discover new and innovative cancer treatment options. ...

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...

How much did Lilly pay radionetics?

Under the terms of the agreement, Radionetics received a $140 million upfront cash payment. As part of the strategic arrangement, Lilly obtained the exclusive right to acquire Radionetics upon conclusion of an exercise period for $1 billion. ...

What is Lilly doing with radionetics?

The biotech kicked off the Phase I study of 68Ga-R8760 in October 2023 and announced plans to launch clinical programs in breast and lung cancer. For Lilly, Monday’s partnership with Radionetics continues its recent investment spree in the radiopharma space. In October 2023, the pharma snapped up Point Biopharma for $1.4 billion. ...

Why is Lilly partnering with radionetics oncology?

"Furthering our commitment to radiopharmaceutical therapies, this relationship provides access to novel GPCR targets and the discovery capabilities of Radionetics Oncology," said Jacob Van Naarden, Executive Vice President and President, Lilly Oncology. ...

Will Lilly buy crinetics?

The agreement also gives Lilly the option to buy the Crinetics spinout for a cool $1 billion at the end of an exercise period. Lilly dived into the nascent radiopharma space by acquiring Point Biopharma for $1.4 billion in late 2023. ...